Robert M. Infarinato's most recent trade in Phio Pharmaceuticals Corp was a trade of 3,000 Common Stock, $0.0001 Par Value done . Disclosure was reported to the exchange on Sept. 11, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Phio Pharmaceuticals Corp | Robert M. Infarinato | VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2024 | 3,000 | 11,000 (0%) | 0% | 0 | Common Stock, $0.0001 Par Value | |
| Phio Pharmaceuticals Corp | Robert M. Infarinato | VP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 8,000 | 8,000 (0%) | 0% | 0 | Common stock, $0.0001 par value |